Verici Dx (LSE:VRCI) Other Long Term Assets : £0.00 Mil (As of Jun. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Verici Dx Other Long Term Assets?

Verici Dx's other long-term assets for the quarter that ended in Jun. 2024 was £0.00 Mil.

Verici Dx's quarterly other long-term assets stayed the same from Jun. 2023 (£0.00 Mil) to Dec. 2023 (£0.00 Mil) but then increased from Dec. 2023 (£0.00 Mil) to Jun. 2024 (£0.00 Mil).

Verici Dx's annual other long-term assets declined from Dec. 2021 (£-0.00 Mil) to Dec. 2022 (£-0.00 Mil) but then increased from Dec. 2022 (£-0.00 Mil) to Dec. 2023 (£0.00 Mil).

Verici Dx Other Long Term Assets Historical Data

The historical data trend for Verici Dx's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Verici Dx Other Long Term Assets Chart

Verici Dx Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

Verici Dx Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Other Long Term Assets	Get a 7-Day Free Trial			-	-	-	-	-

Verici Dx Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Verici Dx Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Verici Dx PLC (LSE:VRCI) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

63V:Germany

Address

19 Stanwell Road, Avon House, Penarth, Cardiff, GBR, CF64 2EZ

Website

https://www.vericidx.com

Verici Dx PLC is an immuno-diagnostics development company. The company is focused on developing diagnostics technologies that will help understand the outcomes of an organ transplant surgery. There are two products for clinical validation and commercialization: Clarava, which is a pre-transplant prognosis for the risk of early acute rejection; and Tuteva, a post-transplant diagnostic focused upon acute cellular rejection including sub-clinical rejection not being diagnosed through the current standard of care of rising serum creatine levels. The business of the Group comprises a single activity, which of the development of prognostic and diagnostic tests for kidney transplant patients.

Verici Dx Headlines

No Headlines